Abstract
Neuropathologists study and make diagnoses of diseases of the brain, spinal cord and skeletal muscle. They use techniques such as gross and microscopic examination, electron microscopy, histochemistry, and immunohistochemistry to assist in making diagnoses of specific diseases. The types of diseases studied by neuropathologists include neoplasms, degenerative diseases, immunologic, metabolic, and vascular diseases. Neuropathologists work closely with neurologists, neurosurgeons, and neuroradiologists to establish specific diagnoses. Diseases diagnosed by neuropathologists include Alzheimer’s disease, chronic traumatic encephalopathy, brain neoplasms, meningiomas, and pituitary neoplasms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jones ML, Alzheimer A. In: van den Tweel JG, editor. Pioneers in pathology. van Krieken JHJM, series editor. Encyclopedia of pathology. Switzerland: Springer International Publishing; 2017. p. 21–23.
Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Research. 2018;7:1161.
Long JM, Holtzman DM. Alzheimer’s disease. An update on pathobiology and treatment strategies. Cell. 2019;179(2):312–39.
Duyckaerts C, De La Tour B, Potier MC. Classification and basic pathology of Alzheimer’s disease. Acta Neuropathol. 2009;118:5–36.
McKee AC, Cairns NJ, Dickson DW, Folkerth RD, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131:75–86.
Smith DH, Johen VE, Trojanowski JQ, et al. Chronic traumatic encephalopathy—confusions and controversies. Nat Rev Neurol. 2019;15(3):179–83.
Concussion. [Film] Directed by: Peter Londesman. USA: Columbia Pictures; 2015.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2016 WHO classification of Tumours of the central nervous system. 4th ed. Lyon: International Agency for Research on Cancer; 2016.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.
Aldape K, Zadeh G, Mansouri S, et al. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129:829–48.
Komori T. The 2016 WHO classification of tumors of the central nervous system: the major points of revision. Neurol Med Chir (Tokyo). 2017;57:301–11.
Soomro SH, Ting LR, Qing YY, et al. Molecular biology of glioblastoma: classification and mutational locations. JPMA. 2017;67(9):1410–4.
Verhaak RGW, Hoadley KA, Purdim E, et al. Integrated genomic analysis identified clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell. 2010;17:98–110.
Buerki RA, Horbinski CM, Kruser T, et al. An overview of meningiomas. Future Oncol. 2018;14(21):2161–77.
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningiomas. J Neuro-Oncol. 2018;99(3):307–14.
Rogers L, Barani L, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcome and uncertainties. A RANO Rev J Neurosurg. 2015;122(1):4–23.
Melmed S. Pituitary-tumor endocrinopathies. New Engl J Med. 2020;382(10):937–50.
Di Ieva A, Rotondo F, Syro LV, Cuisimano MD, Kovacs K. Aggressive pituitary adenomas—diagnosis and emerging treatments. Nat Rev Endocrinol. 2014;10(7):423–35.
Scheithauer BW, Kurtkaya-Yapicier O, Kovacs K, Young WF Jr, Lloyd RV. Pituitary carcinoma: a clinicopathologic review. Neurosurgery. 2005;56(5):1066–74.
Tanizaki Y, Jin L, Scheithauer BW, et al. P53 gene mutations in pituitary carcinomas. Endocr Pathol. 2007;18(4):217–22.
Asa SL, Casar-Borota U, Chanson C, et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET). An international pituitary pathology Club proposal. Endocr Relat Cancer. 2017;24(4):C5–8.
Ho K, Fleseriu M, Kaiser U, et al. Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time? J Endocr Soc. 2021;5(3):bvaa205.
Sigurdson CJ, Bartz JC, Glatzel M. Cellular and molecular mechanisms of prion disease. Annu Rev Pathol Mech Dis. 2019;14:497–516.
Baiardi S, Ross M, Capellari S, et al. Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol. 2019;29:278–300.
Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoform are encoded by the same chromosome gene. Cell. 1986;46:417–28.
Gibbs CJ Jr, Joy A, Heffner R, et al. Clinical and pathologic features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med. 1985;313:734–8.
Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jacob disease associated with blood transfusion: a case report. Lancet. 2006;368:2061–7.
Mut M, Lopez MBS, Shaffrey M. Lucien J Rubinstein enhancing contribution to neuro-oncology. Neurosurg Focus. 2005;18(4):e8.
Davis RL, Kepes JJ, Rorke LB, et al. The art or brain tumor classification—a tribute to Lucien J. Rubinstein (1925–1990). Brain Pathol. 1990;1:55–9.
Kepes JJ. In Memoriam. Lucien J Rubinstein 1924–1990. Acta Neuropathol. 1990;80:108–9.
Barnard RO. Obituary. Professor Lucien J Rubinstein. Neuroradiology. 1990;32:253–4.
Vandenberg S, Scheithauer B, Bignar D. Rubinstein, Lucien J (1924–1990). Memoriam J Neuropath Expt Neurol. 1990;49(5):531–53.
Rubinstein LJ. Discussion on polar spongioblastoma. Acta Neurochir. 1964;11(Suppl10):126.
Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma. A distinct meningocerbral glioma of young subjects with relatively favorable prognosis: a study of 12 cases. Cancer. 1979;44(5):1839–52.
Perry A, Bernd W, Scheithauer MD. Mentor, friend, prodigy. Arch Pathol Lab Med. 2012;136:350–1.
Giannini C. In Memoriam: Bernd Walter Scheithauer (1946–2011). Acta Neuropathol. 2012;123:461–2.
Vandenberg S, Beatriz LM. In Memoriam: Bernd Walter Scheithauer MD August 30, 1946-September 19, 2011. J Neuropathol Expt Neurol. 2012;71(11):1032–5.
Zorludemir S, Scheithauer BW, Hirose T, et al. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol. 1995;19(5):493–505.
Yan X, Marsh WR, Scheithauer BW. Dysembryoplastic neuroepithelial tumor and calcifying pseudoneoplasms of the neuraxis: a collision of two seizure-associated lesions. Clin Neurol. 2011;30(4):197–202.
Pomper MG, Passe TJ, Burger PC, et al. Chordoid glioma: a neoplasm unique to the hypothalamus and anterior third ventricle. AJNR Am J Neuroradiol. 2001;22(3):464–9.
Scheithauer BW, Kovacs K, Horvath E, et al. Pituitary blastoma. Acta Neuropathol. 2008;116(6):657–66.
George DH, Scheithauer BW, Kovacs K, Horvath E, et al. Crooke cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol. 2003;27(10):1330–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lloyd, R.V. (2023). Neuropathology. In: Pathology: Historical and Contemporary Aspects. Springer, Cham. https://doi.org/10.1007/978-3-031-39554-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-39554-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-39553-6
Online ISBN: 978-3-031-39554-3
eBook Packages: MedicineMedicine (R0)